Developed by GlaxoSmithKline in 1991, Zofran (also known by the name of Ondansetron) was initially conceived to help cancer patients. Specifically, its main use was to alleviate the nausea that often accompanied chemotherapy but was also used generally after different kinds of surgeries. In fact, this was the use for which it received FDA approval in the early 1990s. It can be taken orally or via injection. Eventually, doctors began to prescribe its use to pregnant women “off-label” to treat morning sickness and other symptoms associated with pregnancy. “Off-label” refers to the use of medications for persons, amounts, or symptoms for which they were not intended or approved. Generally, doctors would prescribe Zofran to pregnant women when other medications had not been effective.
For additional information see the following pages:
- What types of birth defects in children have been associated with Zofran usage?
- Has the FDA issued any warnings concerning the use of Zofran during pregnancy?
- Has there been a recall of Zofran from the market?
- Have there been any lawsuits filed against the manufacturer of Zofran related to birth defects in children?
- If I took Zofran during my pregnancy and my child was born with birth defects, can I file a legal claim or lawsuit to recover compensation for their injuries?
- Are there any time constraints for pursuing a lawsuit related to Zofran-birth-defects?
- What must be alleged in a Zofran lawsuit in Federal Court?
- What damages are available for myself and my child in a Zofran birth defect lawsuit?
- If a took a generic version of Zofran, can I still pursue a legal claim for damages related to my child’s birth defects?
- Are there any class action lawsuits against GlaxoSmithKline, the manufacturer of Zofran, for children who have birth defects following Zofran usage during pregnancy?